Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT)

Historical Holders from Q2 2019 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
APLT on Nasdaq
Shares outstanding
151,162,791
Price per share
$0.6049
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
94,763,328
Holdings value
$57,199,408
% of all portfolios
0%
Share change
+6,708,167
Value change
+$5,274,161
Average buys %
+0%
Average sells %
-0%
Number of holders
69
Price from insider filings
$0.1120
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 15% +13% $12,946,856 +$1,644,911 21,403,300 +15% T. Rowe Price Investment Management, Inc. 30 Sep 2025
Vestal Point Capital, LP 9.9% $3,680,000 11,500,000 Vestal Point Capital, LP 31 Dec 2024
Alyeska Investment Group, L.P. 5.8% $2,146,399 6,707,497 Alyeska Investment Group, L.P. 31 Dec 2024
ALEXANDRIA REAL ESTATE EQUITIES, INC. 4.3% $1,690,000 6,500,000 Alexandria Real Estate Equities, Inc. 11 Dec 2025
Propel Bio Management, LLC 4.2% $1,564,002 6,015,394 Propel Bio Management, LLC 29 Dec 2025
Venrock Healthcare Capital Partners III, L.P. 4.1% -58% $1,781,667 -$1,996,029 5,567,709 -53% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2025
BlackRock, Inc. 3.7% -54% $2,087,790 -$1,630,640 5,219,475 -44% BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 3.3% -34% $1,893,605 -$462,072 4,734,013 -20% The Vanguard Group 30 Jun 2025
Schonfeld Strategic Advisors LLC 3.3% -53% $1,496,351 -$1,309,934 4,676,097 -47% Schonfeld Strategic Advisors LLC 31 Mar 2025
PERCEPTIVE ADVISORS LLC 2.4% $915,200 2,860,000 Perceptive Advisors LLC 31 Dec 2024
MORGAN STANLEY 2.5% -64% $914,858 -$1,906,110 2,858,931 -68% Morgan Stanley 31 Jan 2025
FRANKLIN RESOURCES INC 1.7% -70% $641,088 -$1,535,203 2,003,400 -71% Franklin Resources, Inc. 31 Dec 2024
JANUS HENDERSON GROUP PLC 0% -104% $11,453 -$3,862,118 35,791 -100% JANUS HENDERSON GROUP PLC 31 Dec 2024
As of 30 Sep 2025, Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) has 69 institutional shareholders filing 13F forms. They hold 94,763,328 shares of 151,162,791 outstanding shares (63%) .

Top 25 institutional shareholders own 61% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
T. Rowe Price Investment Management, Inc. 14% 21,403,300 +15% 0.01% $12,842,000
Vestal Point Capital, LP 9.4% 14,250,000 +24% 0.39% $8,619,825
Propel Bio Management, LLC 7.5% 11,285,420 0% 6.8% $6,826,551
Knoll Capital Management, LLC 5.2% 7,799,687 0% 2.5% $4,711,010
VANGUARD GROUP INC 3.4% 5,102,689 +7.8% 0% $3,087,126
Simplify Asset Management Inc. 3% 4,487,505 0% 0.06% $2,714,492
BlackRock, Inc. 2.5% 3,843,733 -26% 0% $2,325,074
PNC Financial Services Group, Inc. 1.9% 2,901,184 0% $1,755,216
Pathstone Holdings, LLC 1.7% 2,643,540 0% 0.01% $1,599,077
MARSHALL WACE, LLP 1.7% 2,542,688 +65% 0% $1,525,612
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.5% 2,211,629 +83% 0% $1,337,814
Rock Springs Capital Management LP 1.4% 2,075,991 0% 0.07% $1,255,767
FRANKLIN RESOURCES INC 1.3% 2,003,338 0% 0% $1,211,819
MILLENNIUM MANAGEMENT LLC 1.3% 1,907,214 -1.9% 0% $1,153,674
UBS Group AG 1.3% 1,905,625 +129% 0% $1,152,903
GEODE CAPITAL MANAGEMENT, LLC 0.85% 1,278,156 +32% 0% $773,417
Qube Research & Technologies Ltd 0.77% 1,167,269 -36% 0% $706,081
MORGAN STANLEY 0.47% 713,314 +108% 0% $431,484
Hudson Bay Capital Management LP 0.45% 673,764 0% $407,560
DEUTSCHE BANK AG\ 0.41% 622,226 -0% 0% $379,558
STATE STREET CORP 0.34% 518,518 +47% 0% $313,652
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.32% 477,157 -19% 0% $288,632
Rockefeller Capital Management L.P. 0.26% 391,897 0% $237,058
Hennion & Walsh Asset Management, Inc. 0.19% 282,848 -1.8% 0.01% $171,095
Birchview Capital, LP 0.15% 225,000 -20% 0.1% $136,103

Institutional Holders of Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 94,763,328 $57,199,408 +$5,274,161 $0.6049 69
2025 Q2 88,058,885 $27,371,087 -$7,459,107 $0.3111 72
2025 Q1 106,044,815 $51,845,339 -$6,334,869 $0.4889 89
2024 Q4 115,064,985 $98,537,629 -$63,024,633 $0.8562 115
2024 Q3 112,721,874 $960,818,913 +$78,176,291 $8.50 132
2024 Q2 103,226,978 $481,702,604 +$36,986,259 $4.67 96
2024 Q1 93,958,967 $638,614,949 +$219,981,220 $6.80 90
2023 Q4 74,211 $248,607 +$114,607 $3.35 3
2023 Q3 42,970,344 $106,996,633 +$29,097,315 $2.49 53
2023 Q2 31,465,577 $40,275,447 +$15,796,728 $1.28 37
2023 Q1 19,276,881 $15,634,441 +$123,386 $0.8111 33
2022 Q4 19,356,004 $14,709,202 -$2,557,195 $0.7600 34
2022 Q3 22,671,476 $21,085,595 -$3,111,066 $0.9302 37
2022 Q2 26,599,107 $25,217,765 +$12,928,055 $0.9481 44
2022 Q1 12,317,637 $25,974,133 -$34,488,747 $2.11 65
2021 Q4 14,884,072 $133,206,527 -$7,905,162 $8.95 63
2021 Q3 15,109,010 $250,904,842 -$6,059,661 $16.60 67
2021 Q2 15,367,588 $319,342,018 +$9,971,179 $20.78 67
2021 Q1 14,020,090 $262,950,177 +$48,106,175 $18.76 65
2020 Q4 11,666,056 $256,772,809 -$1,664,771 $22.01 64
2020 Q3 12,193,459 $253,134,571 -$3,365,537 $20.76 62
2020 Q2 11,284,493 $407,413,612 +$70,291,696 $36.15 68
2020 Q1 9,642,088 $315,202,419 +$155,197,467 $32.69 60
2019 Q4 4,991,742 $136,175,281 +$71,228,487 $27.28 45
2019 Q3 2,391,132 $26,278,659 +$2,238,633 $10.99 27
2019 Q2 2,168,472 $17,869,000 +$17,869,011 $8.24 12